Segment Information (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 30, 2013	Mar. 31, 2012	Mar. 30, 2013 segments	Mar. 31, 2012
Segment Reporting Information [Line Items]
Number of reporting segments			4
Net sales	$ 919,825	$ 778,017	$ 2,572,594	$ 2,341,482
Operating income	178,606	146,070	499,036	408,290
Intangible assets amortization expense	24,612	18,532	64,958	56,313
Total Assets	4,495,888	4,040,054	4,495,888	4,040,054
Consumer Healthcare [Member]
Segment Reporting Information [Line Items]
Net sales	536,775	448,848	1,526,479	1,331,806
Operating income	95,921	79,383	261,287	230,822
Intangible assets amortization expense	5,030	2,421	12,163	6,886
Total Assets	1,724,585	1,658,231	1,724,585	1,658,231
Nutritionals [Member]
Segment Reporting Information [Line Items]
Net sales	133,344	117,683	358,705	365,691
Operating income	6,965	1,845	18,008	13,638
Intangible assets amortization expense	7,310	6,637	21,920	22,739
Total Assets	951,113	952,761	951,113	952,761
Rx Pharmaceuticals [Member]
Segment Reporting Information [Line Items]
Net sales	189,410	155,591	514,893	460,414
Operating income	73,419	67,257	205,982	161,716
Intangible assets amortization expense	11,351	8,574	28,210	23,896
Total Assets	1,433,788	1,066,559	1,433,788	1,066,559
API [Member]
Segment Reporting Information [Line Items]
Net sales	41,114	36,951	118,387	127,347
Operating income	11,728	10,462	38,867	36,370
Intangible assets amortization expense	498	490	1,442	1,507
Total Assets	278,957	266,786	278,957	266,786
All Other Segments [Member]
Segment Reporting Information [Line Items]
Net sales	19,182	18,944	54,130	56,224
Operating income	1,642	846	2,730	2,055
Intangible assets amortization expense	423	410	1,223	1,285
Total Assets	107,445	95,717	107,445	95,717
Unallocated Amount to Segment [Member]
Segment Reporting Information [Line Items]
Net sales	0	0	0	0
Operating income	(11,069)	(13,723)	(27,838)	(36,311)
Intangible assets amortization expense	0	0	0	0
Total Assets	$ 0	$ 0	$ 0	$ 0